ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,391Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 2888

$2.08M Total Retail Price of All Prescriptions

Rank: 22 out of 2888

1,041 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 1,041 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 27,137 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
CRESTOR 1,290 1,072 1 20
LEVOTHYROXINE SODIUM 1,243 1,095 2 1
SIMVASTATIN 1,139 889 3 2
IBUPROFEN 1,128 936 10 4 87
NEXIUM 973 853 5 19
ATORVASTATIN CALCIUM 728 643 6 9
METOPROLOL SUCCINATE 728 642 6 11
AMLODIPINE BESYLATE 724 637 8 5
CLOTRIMAZOLE-BETAMETHASONE 719 608 10 9 136
FUROSEMIDE 691 649 10 6
HYDROCODONE-ACETAMINOPHEN 665 399 S3 11 4
GLYBURIDE-METFORMIN HCL 638 511 R 12 64
DONEPEZIL HCL 628 605 13 26
TAMSULOSIN HCL 598 567 14 29
EXFORGE 597 539 10 15 159
LISINOPRIL 590 456 16 3
AMLODIPINE BESYLATE-BENAZEPRIL 533 503 17 67
DIOVAN 452 437 18 35
NITROGLYCERIN PATCH 421 406 19 183
JANUMET 413 317 20 131
NAPROXEN 405 350 21 80
OMEPRAZOLE 392 362 22 7
CLOPIDOGREL 372 318 23 30
LEVOFLOXACIN 353 295 24 57
NAMENDA 331 331 25 34
CARVEDILOL 325 274 26 21
TRAMADOL HCL 317 258 27 16
ZOLPIDEM TARTRATE 310 216 28 17
PANTOPRAZOLE SODIUM 299 212 29 33
MEGESTROL ACETATE 278 269 R 30 140
PLAVIX 265 232 31 40
DIGOXIN 265 234 31 55
VOLTAREN 262 247 33 157
DIOVAN HCT 256 236 34 61
ALLOPURINOL 246 228 35 37
ISOSORBIDE MONONITRATE ER 228 200 36 51
LACTULOSE 225 206 37 111
ENALAPRIL MALEATE 222 193 38 49
NIFEDIPINE ER 196 166 39 76
GLIMEPIRIDE 193 171 40 36
CILOSTAZOL 183 171 41 165
JANUVIA 182 143 42 48
RANITIDINE HCL 181 126 43 56
ESCITALOPRAM OXALATE 181 172 43 62
NOVOLOG MIX 70-30 180 135 45 209
SERTRALINE HCL 172 100 46 27
TRIAMTERENE-HYDROCHLOROTHIAZID 171 160 47 259
LISINOPRIL-HYDROCHLOROTHIAZIDE 167 135 48 28
AMOXICILLIN 163 128 49 117
PRAVASTATIN SODIUM 161 145 50 12
LIPITOR 151 144 51 78
PREDNISONE 149 120 52 42
CARBIDOPA-LEVODOPA 147 147 53 113
PHENYTOIN SODIUM EXTENDED 140 72 54 128
SINGULAIR 137 113 55 85
CIPROFLOXACIN HCL 136 111 56 47
POTASSIUM CHLORIDE 129 116 57 14
EXFORGE HCT 128 121 58 303
ACTOS 124 108 59 108
INSULIN SYRINGE 123 93 60 86
WARFARIN SODIUM 119 99 61 22
ALBUTEROL SULFATE 117 116 62 134
LYRICA 115 98 63 69
KLOR-CON M20 113 108 64 90
AZITHROMYCIN 113 86 64 38
METOPROLOL TARTRATE 112 102 66 10
AVODART 111 109 67 151
SULFAMETHOXAZOLE-TRIMETHOPRIM 109 81 68 88
CARAFATE 108 102 69 408
LOSARTAN POTASSIUM 105 103 70 18
METFORMIN HCL ER 104 84 71 53
TRICOR 103 83 72 91
GABAPENTIN 101 63 73 13
METFORMIN HCL 99 64 74 8
MECLIZINE HCL 98 90 75 122
NOVOLIN R 97 75 76 109
QUETIAPINE FUMARATE 96 74 77 66
TRAMADOL HCL-ACETAMINOPHEN 96 77 77 95
JANTOVEN 95 88 79 163
GENERLAC 95 62 79 318
ATENOLOL 93 49 81 25
LANTUS 91 71 82 45
CYCLOBENZAPRINE HCL 86 45 R 83 68
MELOXICAM 86 81 83 31
CITALOPRAM HBR 85 57 85 24
KLOR-CON M10 83 80 86 118
LIDODERM 83 65 86 105
DILTIAZEM 24HR CD 81 76 88 146
VYTORIN 81 81 88 155
FAMOTIDINE 80 68 90 75
DEXILANT 80 70 90 186
LOSARTAN-HYDROCHLOROTHIAZIDE 79 67 92 46
ENABLEX 78 66 93 269
GLYBURIDE 71 56 R 94 58
MONTELUKAST SODIUM 70 56 95 153
PREDNISOLONE ACETATE 70 52 95 522
CELEBREX 68 67 97 89
NIFEDICAL XL 68 68 97 190
AMLODIPINE-ATORVASTATIN 67 52 99 469
LABETALOL HCL 66 36 100 180
AMIODARONE HCL 65 65 101 167
CYMBALTA 65 49 101 44
EXELON 62 62 103 106
PAROXETINE HCL 62 50 103 84
RAMIPRIL 62 49 103 73
LEXAPRO 62 61 103 198
HYDRALAZINE HCL 61 52 107 59
FINASTERIDE 60 50 108 102
HYDROCHLOROTHIAZIDE 59 30 109 15
PIOGLITAZONE HCL 58 49 R 110 248
RISPERIDONE 58 49 110 72
GLIPIZIDE 57 57 112 50
NEOMYCIN-POLYMYXIN-HYDROCORT 56 42 113 568
HALOPERIDOL 55 41 114 282
CLONIDINE HCL 55 17 114 39
CEPHALEXIN 55 42 114 119
DICLOFENAC SODIUM 55 40 114 141
GENTAMICIN SULFATE 55 44 114 320
LEVEMIR 54 43 119 135
CARISOPRODOL 54 22 R 119 82
HYDROXYZINE HCL 53 44 R 121 174
NASONEX 50 42 122 168
SUCRALFATE 50 47 122 187
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.